Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update
Abstract
ASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual . The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information ( Appendix 1 and Appendix 2 , online only).
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (17)
Hans Messersmith
American Society of Clinical Oncology (ASCO), Alexandria, VA
Andrew B. Lassman
Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, New York-Presbyterian, New York, NY
Jaishri Blakeley
Johns Hopkins University School of Medicine, Baltimore, MD
Na Tosha Gatson
Andreas F. Hottinger
Andrew Lassman
Nimish A. Mohile
Department of Neurology and Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
Jordan Morton
Douglas Ney
2University of Colorado, Department of Neurology, Aurora, United States
Phioanh Leia Nghiemphu
Department of Neurology, University of California, Los Angeles, Los Angeles, CA
James Perry
University of Maryland, Baltimore, MD, USA.
David Schiff
31Department of Neurology, Division of Neuro-Oncology, University of Virginia, Charlottesville, VA
Anne Shannon
Helen A. Shih
Department of Radiation Oncology, Mass General Brigham & Harvard Medical School, Boston, MA
Roy Strowd
3Department of Cancer Medicine, Atrium Health Wake Forest University School of Medicine, Winston-Salem, United States
Martin van den Bent
Mateo Ziu